Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.
Clinical trial NCT03460678 · TERMINATED
Trial details
- NCT number
- NCT03460678
- Sponsor
- Hikma Pharmaceuticals LLC
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2018-11-14
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.